Related Experiment Video
Updated: May 12, 2026
Recombinant Protein Expression for Structural Biology in HEK 293F Suspension Cells: A Novel and Accessible Approach
Published on: October 16, 2014
Optimization of CYP27A1 recombinant protein expression
Johanna E Papa1, Lindsay R Vaughn1, Jackson L Bartholomew-Schoch1
1Department of Chemistry and Fermentation Sciences, Appalachian State University, Boone, NC, USA.
Abstract:
Human mitochondrial cytochrome P450 27A1 is a monooxygenase enzyme that oxidizes bile acids and other sterol derivatives. The enzyme plays an important role in sterol metabolism and is a potential target for clinical therapies related to metabolic conditions and certain cancers. To support the development of such therapies, detailed structural and functional studies of the enzyme should be pursued. Producing large quantities of purified, recombinant enzyme would enable these studies. Recombinant production of human cytochrome P450 27A1 in E. coli is challenging due to the enzyme being membrane associated. This work explores the optimization of human cytochrome P450 27A1 expression in E. coli by systematically testing the effects of cell strain, expression temperature, concentrations of induction reagents, and expression times. Western blot analysis is used to investigate the effects of variable changes prior to purification. E. coli cell strain (switching to C41(DE3)) appears to have the largest positive effect on overall yield. Increasing δ-aminolevulinic acid concentration (induces heme synthesis) also leads to significantly increased yields. Decreasing expression time decreases the amount of higher order cytochrome P450 aggregates that are formed. The combination of these changes is a more robust expression protocol with three major advantages: decreased expression time, lower aggregate to monomer ratios, and increased overall yield.
Insights
Optimizing recombinant human cytochrome P450 27A1 production in E. coli, a key enzyme in sterol metabolism, was achieved by modifying cell strain and induction conditions. This improved yield and reduced aggregate formation for enhanced structural and functional studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Human mitochondrial cytochrome P450 27A1 (CYP27A1) is crucial for sterol metabolism, involved in bile acid oxidation.
- CYP27A1 is a potential therapeutic target for metabolic diseases and cancers.
- Structural and functional studies require large quantities of purified, recombinant CYP27A1.
Purpose of the Study:
- To optimize the recombinant expression of human CYP27A1 in E. coli.
- To overcome challenges associated with membrane-associated protein production.
- To develop a robust protocol for increased yield and purity.
Main Methods:
- Systematic optimization of E. coli expression conditions.
- Testing effects of cell strain (e.g., C41(DE3)), temperature, induction reagent concentrations, and expression times.
- Utilizing Western blot analysis to assess protein expression and aggregation.
Main Results:
- Switching to E. coli C41(DE3) cell strain significantly increased overall yield.
- Increasing δ-aminolevulinic acid concentration enhanced CYP27A1 yields by inducing heme synthesis.
- Decreasing expression time reduced the formation of higher-order CYP450 aggregates.
Conclusions:
- A refined E. coli expression protocol was established for human CYP27A1.
- The optimized protocol offers decreased expression time, lower aggregate ratios, and increased yield.
- This facilitates structural and functional studies critical for therapeutic development.
